Boston Scientific (BSX) Financials: Revenue & Earnings

BSX price $43.06 -2.00 -4.43%

Ticker
BSX
Price
$43.06
Change
-2.00 -4.43%
Market cap ?
$62.41B
P/E ?
18.38
Forward P/E ?
13.34
Dividend yield ?
0.00%
Beta ?
0.57
Sector
Healthcare
Industry
Medical - Devices
Stocklytics score
68
Value
74
Quality
61
Growth
70

Stocklytics score rationale: value 74, quality 61, growth 70.

Financials

2016201720182019202020212022202320242025
8386000000904800000098230000001073500000099130000001188800000012682000000142400000001674700000020074000000

Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the…

Fair value

BSX fair value $108.64. Price $43.06. Price is 60% below fair value.

Below fair value, and cheaper than usual. A larger discount than on more than 99% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 3.62B. Growth 10.02%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 1.45B. Net debt 10.37B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare BSX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-10-280.730.725.14B5.06B
2026-07-290.860.835.44B5.38B
2026-04-220.800.795.20B5.17B
2026-02-040.800.785.29B5.28B
2025-10-220.750.715.07B4.97B
2025-07-230.750.725.06B4.89B
2025-04-230.750.674.66B4.57B
2025-02-050.700.664.56B4.42B
2024-10-230.630.594.21B4.04B
2024-07-240.620.584.12B4.03B
2024-04-240.560.513.86B3.68B
2024-01-310.550.513.73B3.59B
2023-10-260.500.483.53B3.47B
2023-07-270.530.493.60B3.50B
2023-04-260.470.433.39B3.16B
2023-02-010.450.473.24B3.24B
2022-10-260.430.443.17B3.14B
2022-07-270.440.423.24B3.22B
2022-04-270.390.383.03B2.96B
2022-02-020.450.443.13B3.11B
2021-10-270.410.402.93B3.00B
2021-07-270.400.373.08B3.02B
2021-04-280.370.302.75B2.62B
2021-02-030.230.312.71B2.81B
2020-10-280.370.252.66B2.28B
2020-07-290.080.022.00B500.75M
2020-04-290.280.332.54B2.82B
2020-02-050.460.442.90B2.78B
2019-10-230.390.382.71B2.64B
2019-07-240.390.382.63B2.56B
2019-04-240.350.362.49B2.56B
2019-02-060.390.372.56B2.43B
2018-10-240.350.342.39B2.32B
2018-07-250.410.342.49B2.42B
2018-04-250.330.312.38B2.31B
2018-02-010.340.342.41B2.41B
2017-10-260.310.312.22B2.22B
2017-07-270.320.312.26B2.19B
2017-04-270.290.302.16B2.23B
2017-02-020.300.292.19B2.12B

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-02O'Connor Padraig AndrewBuy1.17K——
2026-09-02O'Connor Padraig AndrewSell567$48.3727.43K
2026-09-02O'Connor Padraig AndrewSell1.17K——
2026-08-25Morano Susan EBuy2.04K$49.22100.41K
2026-08-11Woodworth EmilyBuy2.93K$51.19149.99K
2026-08-10Monson JonathanBuy9.91K$50.46499.96K
2026-08-05Habiger David CBuy2.10K$47.5999.94K
2026-08-04Habiger David CBuy140$48.596.80K
2026-08-03Habiger David CBuy1.04K$48.0750.08K
2026-08-03Mahoney Michael FBuy186.24K$48.339.00M
2026-08-03Mahoney Michael FBuy22.12K$48.431.07M
2026-07-31LUDWIG EDWARD JBuy5.00K$45.48227.40K
2026-07-31Fitzgerald Joseph MichaelBuy64.20K$46.733.00M
2026-07-01Monson JonathanBuy2.09K——
2026-07-01Monson JonathanSell1.01K$43.0643.49K
2026-07-01Monson JonathanSell2.09K——
2026-05-28Mahoney Michael FSell386.75K——
2026-05-20Pegus CherylBuy1.77K$56.4999.99K
2026-05-20LUDWIG EDWARD JBuy3.58K$56.68202.91K
2026-05-20Habiger David CBuy2.25K$55.92125.82K
2026-05-19Habiger David CBuy2.20K$56.95125.28K
2026-05-07Zane Ellen MBuy3.80K——
2026-05-07WICHMANN DAVID SBuy3.80K——
2026-05-07Weber Christophe PierreBuy1.14K——
2026-05-07Weber Christophe PierreBuy2.66K——
2026-05-07Weber Christophe PierreBuy1.77K——
2026-05-07Smith Cathy RBuy2.21K——
2026-05-07Smith Cathy RBuy3.80K——
2026-05-07Pegus CherylBuy1.28K——
2026-05-07Pegus CherylBuy3.80K——
2026-05-07Morano Susan EBuy1.28K——
2026-05-07Morano Susan EBuy3.80K——
2026-05-07Mega Jessica LBuy3.80K——
2026-05-07LUDWIG EDWARD JBuy3.80K——
2026-05-07Habiger David CBuy3.80K——
2026-05-02O'Connor Padraig AndrewBuy1.80K——
2026-05-02O'Connor Padraig AndrewSell872$56.5049.27K
2026-05-02O'Connor Padraig AndrewSell1.80K——
2026-05-02Butcher Arthur CBuy2.10K——
2026-05-02Butcher Arthur CSell1.01K$56.5056.90K
2026-05-02Butcher Arthur CSell2.10K——
2026-03-02Pegus CherylBuy24——
2026-03-02Morano Susan EBuy24——
2026-03-02Weber Christophe PierreBuy323——
2026-03-02Weber Christophe PierreBuy556——
2026-03-02Smith Cathy RBuy323——
2026-03-02Smith Cathy RBuy556——
2026-03-01Woodworth EmilyBuy838——
2026-03-01Woodworth EmilySell372$76.8528.59K
2026-03-01Woodworth EmilySell838——
2026-02-19Butcher Arthur CBuy6.85K$75.76519.03K
2026-02-18Weber Christophe PierreOther0——
2026-02-18Smith Cathy ROther0——
2026-02-16O'Connor Padraig AndrewBuy905——
2026-02-16O'Connor Padraig AndrewSell339$74.7325.33K
2026-02-16O'Connor Padraig AndrewSell905——
2026-02-16Woodworth EmilyBuy637——
2026-02-16Woodworth EmilySell283$74.7321.15K
2026-02-16Woodworth EmilySell637——
2026-02-16Monson JonathanBuy990——
2026-02-16Monson JonathanSell440$74.7332.88K
2026-02-16Monson JonathanSell990——
2026-02-16O'Sullivan MiriamBuy990——
2026-02-16O'Sullivan MiriamSell291$74.7321.75K
2026-02-16O'Sullivan MiriamSell990——
2026-02-16Mahoney Michael FBuy16.27K——
2026-02-16Mahoney Michael FSell7.87K$74.73587.75K
2026-02-16Mahoney Michael FSell16.27K——
2026-02-16Fitzgerald Joseph MichaelBuy3.96K——
2026-02-16Fitzgerald Joseph MichaelSell1.81K$74.73134.96K
2026-02-16Fitzgerald Joseph MichaelSell3.96K——
2026-02-16Butcher Arthur CBuy2.55K——
2026-02-16Butcher Arthur CSell1.23K$74.7391.84K
2026-02-16Butcher Arthur CSell2.55K——
2026-02-16Brown Vance RBuy1.84K——
2026-02-16Brown Vance RSell890$74.7366.51K
2026-02-16Brown Vance RSell1.84K——
2026-02-14O'Connor Padraig AndrewBuy1.19K——
2026-02-14O'Connor Padraig AndrewSell449$74.7333.55K
2026-02-14O'Connor Padraig AndrewSell1.19K——
2026-02-14Woodworth EmilyBuy661——
2026-02-14Woodworth EmilySell296$74.7322.12K
2026-02-14Woodworth EmilySell661——
2026-02-14Monson JonathanBuy1.06K——
2026-02-14Monson JonathanSell470$74.7335.12K
2026-02-14Monson JonathanSell1.06K——
2026-02-14O'Sullivan MiriamBuy1.12K——
2026-02-14O'Sullivan MiriamSell329$74.7324.59K
2026-02-14O'Sullivan MiriamSell1.12K——
2026-02-14Mahoney Michael FBuy16.52K——
2026-02-14Mahoney Michael FSell7.99K$74.73597.09K
2026-02-14Mahoney Michael FSell16.52K——
2026-02-14Fitzgerald Joseph MichaelBuy4.36K——
2026-02-14Fitzgerald Joseph MichaelSell1.99K$74.73148.71K
2026-02-14Fitzgerald Joseph MichaelSell4.36K——
2026-02-14Butcher Arthur CBuy3.17K——
2026-02-14Butcher Arthur CSell1.53K$74.73114.71K
2026-02-14Butcher Arthur CSell3.17K——
2026-02-14Brown Vance RBuy1.85K——
2026-02-14Brown Vance RSell895$74.7366.88K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 1.58K, holders -191 vs prior quarter. Ownership 90.62%.

HolderSharesChangeChange %Value
BLACKROCK, INC.129.68M-2.14M-1.62%5.53B
VANGUARD CAPITAL MANAGEMENT LLC97.09M675.99K+0.70%4.14B
STATE STREET CORP70.11M2.12M+3.12%2.99B
PRIMECAP MANAGEMENT CO/CA/50.52M17.99M+55.31%2.16B
FMR LLC45.70M-28.52M-38.43%1.95B
MASSACHUSETTS FINANCIAL SERVICES CO /MA/24.86M13.86M+126.06%1.50B
GEODE CAPITAL MANAGEMENT, LLC33.44M154.34K+0.46%1.42B
VANGUARD PORTFOLIO MANAGEMENT LLC29.79M-3.42K-0.01%1.27B
D. E. SHAW & CO., INC.25.46M1.15M+4.71%1.09B
JPMORGAN CHASE & CO23.91M-9.44M-28.31%1.04B
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP23.29M9.40M+67.68%994.18M
NORGES BANK21.17M21.17MNew903.54M
TWO SIGMA INVESTMENTS, LP19.36M9.95M+105.70%826.24M
MORGAN STANLEY18.95M-3.32M-14.91%808.66M
JUPITER TOPCO LLC18.82M18.82MNew803.36M
BOLLARD GROUP LLC18.42M-111.45K-0.60%786.20M
GOLDMAN SACHS GROUP INC16.95M-1.94M-10.25%723.61M
CAPITAL WORLD INVESTORS16.81M1.50M+9.81%717.60M
UBS GROUP AG16.35M1.53M+10.31%697.92M
JANE STREET GROUP, LLC16.09M12.05M+298.96%686.58M
WELLINGTON MANAGEMENT GROUP LLP15.30M-3.53M-18.75%653.08M
AMUNDI14.30M173.21K+1.23%610.16M
CAPITAL RESEARCH GLOBAL INVESTORS14.18M7.10M+100.27%605.26M
INVESCO LTD.13.80M4.75M+52.46%589.02M
FRANKLIN TEMPLETON INC13.77M-726.42K-5.01%587.80M

Earnings and financials

Boston Scientific Corporation (BSX) trades at $43.06, with a market cap of $62.41B and a trailing P/E of 18.38. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
8386000000904800000098230000001073500000099130000001188800000012682000000142400000001674700000020074000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Boston Scientific (BSX) Financials: Revenue & Earnings

BSX$43.06-2.00 -4.43%

$62.41B

Market Cap

18.38

P/E

13.34

Forward P/E

68

Score

Price History